posted on 2020-04-02, 16:30authored byMarcela Krečmerová, Antonín Holý, Alois Pískala, Milena Masojídková, Graciela Andrei, Lieve Naesens, Johan Neyts, Jan Balzarini, Erik De Clercq, Robert Snoeck
Treatment of 5-azacytosine sodium salt with diisopropyl [(2-chloroethoxy)methyl]phosphonate followed by
removal of ester groups with BrSi(CH3)3 afforded 1-[2-(phosphonomethoxy)ethyl]-5-azacytosine (3). Reaction
of 5-azacytosine with [(trityloxy)methyl]-(2S)-oxirane followed by etherification with diisopropyl (bromomethyl)phosphonate and removal of ester groups gave 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine (1). The synthesis of 6-azacytosine congener 2 was analogous using N4-benzoylated
intermediates. Compound 1 was shown to exert strong activity against a broad spectrum of DNA viruses
including adenoviruses, poxviruses, and herpesviruses (i.e., herpes simplex viruses, varicella zoster virus,
and human cytomegalovirus). Decomposition of 1 in alkaline solutions resulted in products 17 and 18.
While the N-formylguanidine derivative 17 proved active, the carbamyolguanidine derivative 18 was devoid
of antiviral activity.